» Articles » PMID: 1835374

Evaluation of Different Methods of Inactivation of Newcastle Disease Virus and Avian Influenza Virus in Egg Fluids and Serum

Overview
Journal Avian Dis
Date 1991 Jul 1
PMID 1835374
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Viruses conveyed in shipments of eggs, viral diagnostic reagents, or avian serum samples are a potential hazard for susceptible poultry. Different methods of treatment of those materials to eliminate the hazard of virulent and avirulent strains of Newcastle disease virus (NDV) or avian influenza virus (AIV) were evaluated. The NDV strains tested were more thermostable than the AIV strains. The results suggest that standard pasteurization methods would not reliably inactivate the concentrations of NDV used. beta-Propiolactone (BPL) (greater than or equal to 0.025%) inactivated NDV or AIV in allantoic fluid, but higher concentrations were needed to inactivate virus diluted in serum. Hemagglutination (HA) of NDV and AIV and hemolysis (HL) activity of NDV were reduced or eliminated by 0.4% BPL. Formalin (greater than or equal to 0.04%) inactivated either virus but adversely affected HA and HL activity. NDV or AIV was inactivated by binary ethylenimine (BEI) (0.01 M) with no adverse effect on HA or HL. Heat (56 C) or BEI (0.01 M) had no apparent effect on hemagglutination-inhibition (HI) titers of NDV and AIV antisera, the effect of formalin (0.1%) was variable, and BPL (greater than or equal to 0.25%) depressed the HI titers of both antisera. The optimum method should achieve virus inactivation without harming the treated material.

Citing Articles

Comparative evaluation of protective efficacy of experimental inactivated vaccines against haemorrhagic septicaemia.

Dhakarwal P, Medhi M, Muthuchelvan D, Chaudhuri P, Viswas K, Patel B Braz J Microbiol. 2025; 56(1):651-663.

PMID: 39832111 PMC: 11885734. DOI: 10.1007/s42770-024-01610-9.


Assessment of Different Newcastle Disease Virus Antigens and Inactivators of Binary Ethylene Amine and Formalin for the Hemagglutination Inhibition Assay.

Rahmanzad F, Amini Najafi F, Bahonar A, Parvandar Asadollahi K Arch Razi Inst. 2024; 79(2):437-444.

PMID: 39463717 PMC: 11512190. DOI: 10.32592/ARI.2024.79.2.437.


The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-Zoonotic Avian Influenza and .

Blacksell S, Dhawan S, Kusumoto M, Le K, Summermatter K, OKeefe J Appl Biosaf. 2023; 28(3):135-151.

PMID: 37736423 PMC: 10510692. DOI: 10.1089/apb.2022.0038.


Inactivation of Viable Surrogates for the Select Agents Virulent Newcastle Disease Virus and Highly Pathogenic Avian Influenza Virus Using Either Commercial Lysis Buffer or Heat.

Alger K, Ip H, Hall J, Nashold S, Richgels K, Smith C Appl Biosaf. 2022; 24(4):189-199.

PMID: 36032057 PMC: 9134477. DOI: 10.1177/1535676019888920.


Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes.

Bortolami A, Mazzetto E, Kangethe R, Wijewardana V, Barbato M, Porfiri L Front Vet Sci. 2022; 9:916108.

PMID: 35898545 PMC: 9309530. DOI: 10.3389/fvets.2022.916108.